Aussie, as far as I know Breast Cancer is not directly on BLT's agenda. However, there are numerous teams around the world that are using ddrnai as possible treatment for the disease.
From contacts I have made in the scientific community it would seem that a clinical trial for ddrnai against breast cancer is due to start in shortly in China and, if $ are available, another trial will start in Vietnam next year.
I believe that breast cancer is also being tackled by Gradalis but I am not sure when they will take this to the clinic.
As there are so many teams close to the clinic (and lots more doing pre-clinical work)it is probably not worthwhile for BLT to pursue its own program in breast cancer.
- Forums
- ASX - By Stock
- BLT
- china buying into genome sequencing
china buying into genome sequencing, page-38
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online